Does Humira List Dizziness as a Side Effect?
Yes, dizziness is a reported side effect of Humira (adalimumab), an injectable biologic used for autoimmune conditions like rheumatoid arthritis, psoriasis, and Crohn's disease. Clinical trials and post-marketing data show it occurs in about 3-7% of patients, typically mild and transient.[1][2]
How Common Is Dizziness with Humira?
In pivotal trials:
- Rheumatoid arthritis studies: 5-7% of Humira users reported dizziness vs. 4% on placebo.
- Psoriatic arthritis: Around 3%.
- It ranks as a less common nervous system effect, behind headaches (12-14%). Rates vary by dose (40mg every other week standard) and patient factors like age or concurrent meds.[2][3]
Why Does Humira Cause Dizziness?
Humira blocks TNF-alpha, reducing inflammation but sometimes disrupting blood pressure regulation or nerve signaling. Possible mechanisms:
- Vasovagal response from injection.
- Interaction with blood pressure meds (e.g., antihypertensives).
- Rarely, links to anemia or infections, which Humira increases risk for.[1][4]
What Do Patients Report About Humira Dizziness?
Real-world data from FDA adverse event reports (FAERS) logs over 5,000 dizziness cases linked to Humira since 2002, often with fatigue or nausea. Forums like Drugs.com show 4-6% user ratings mention it, peaking in first months of treatment.[5][6] Onset: Usually within hours of injection, resolving in days.
When Should You Worry About Dizziness on Humira?
Most cases are benign, but seek medical help if:
- Severe, sudden, or with fainting (could signal low blood pressure or stroke risk).
- Paired with vision changes, chest pain, or infection signs (Humira suppresses immunity).
- Persistent beyond 48 hours—dose adjustment or pause may be needed.[1][3]
How Does Humira Dizziness Compare to Similar Drugs?
| Drug | Dizziness Rate | Notes |
|------|---------------|-------|
| Humira (adalimumab) | 3-7% | Injection-related. |
| Enbrel (etanercept) | 4-8% | Similar TNF blocker; slightly higher. |
| Stelara (ustekinumab) | 2-4% | IL-12/23 inhibitor; lower incidence. |
| Cosentyx (secukinumab) | 3-5% | IL-17 blocker; comparable but fewer reports. [2][7] |
Switching biologics sometimes reduces it.
Managing or Avoiding Dizziness on Humira